The broad objective of this application is to identify neural mechanisms that cause migraineurs to seek sanctuary in the dark during attacks in effort to escape what they describe as """"""""my head hurts more and I feel worse when I am exposed to light"""""""". The long-term objectives are to identify the impact of light on sensory, affective and autonomic neurological functions during migraine (human study), and discover the neural pathways through which lights alter these functions (animal study). Leading up to this grant proposal are years of listening to patients'testimonies which taught us that exposure to different kind of lights can trigger different symptoms in migraineurs with normal eyesight as compared to blind and color-blind migraineurs. Based on what we heard, we postulated that exacerbation of headache by light is one of many reasons why migraineus seek the dark during migraine and that different colors of lights have the capacity to trigger different neurological symptoms. Mechanistically, we hypothesized that during migraine, activity of neurons in brain regions that mediate different aspects of sensory, emotional, and autonomic responses to pain is modulated by both headache and light through signals transmitted to them from the spinal trigeminal nucleus and the optic nerve. In the clinical study, we will determine the effects of different colos of light on the intensity of migraine headache and its many associated symptoms. Two groups of migraineurs (normal eyesight and visually-impaired) and a control group will be expose to different intensities of white, blue, green, yellow and red lights (delivered through an FDA-approved photic stimulator) when they are pain-free and during an attack. Data analysis and interpretation will include strength of electroretinography and visual evoked potential signals (waveforms) as well as documentation of sensory, affective and physiological changes. In the animal study, we will determine whether neurons that play a role in the neurological symptoms that are altered by light in patients receive direct input from the retina and brain areas involved in the transmission of migraine headache. These studies will combine psychophysical observations in human subjects with tract-tracing, immunohistochemical, molecular and physiological techniques in animals.

Public Health Relevance

Photophobia often renders migraineurs dysfunctional as they are force to seek dark environment. The proposed research holds the key to the development of novel therapeutic strategies for preventing photophobia during migraine. The findings are also likely to advance our understanding of photophobia in individuals diagnosed with different types of retinal degenerative diseases, thus leading us a step closer to alleviating it.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37NS079678-02
Application #
8499450
Study Section
Special Emphasis Panel (ZRG1-IFCN-Q (02))
Program Officer
Porter, Linda L
Project Start
2012-07-01
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
2
Fiscal Year
2013
Total Cost
$419,775
Indirect Cost
$178,525
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Schain, Aaron J; Melo-Carrillo, Agustin; Borsook, David et al. (2018) Activation of pial and dural macrophages and dendritic cells by cortical spreading depression. Ann Neurol 83:508-521
Nir, Rony-Reuven; Lee, Alice J; Huntington, Shaelah et al. (2018) Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls. Pain 159:2030-2034
Solstrand Dahlberg, Linda; Linnman, Clas N; Lee, Danielle et al. (2018) Responsivity of Periaqueductal Gray Connectivity Is Related to Headache Frequency in Episodic Migraine. Front Neurol 9:61
Melo-Carrillo, Agustin; Strassman, Andrew M; Nir, Rony-Reuven et al. (2017) Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (A?) But Not Unmyelinated (C) Meningeal Nociceptors. J Neurosci 37:10587-10596
Melo-Carrillo, Agustin; Noseda, Rodrigo; Nir, Rony-Reuven et al. (2017) Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody. J Neurosci 37:7149-7163
Schain, Aaron J; Melo-Carrillo, Agustin; Strassman, Andrew M et al. (2017) Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache. J Neurosci 37:2904-2915
Youssef, Andrew M; Ludwick, Allison; Wilcox, Sophie L et al. (2017) In child and adult migraineurs the somatosensory cortex stands out … again: An arterial spin labeling investigation. Hum Brain Mapp 38:4078-4087
Noseda, Rodrigo; Borsook, David; Burstein, Rami (2017) Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache. Headache 57 Suppl 2:97-111
Becerra, Lino; Bishop, James; Barmettler, Gabi et al. (2017) Brain network alterations in the inflammatory soup animal model of migraine. Brain Res 1660:36-46
Burstein, Rami (2017) Reply: Pupil area and photopigment spectral sensitivity are relevant to study of migraine photophobia. Brain 140:e3

Showing the most recent 10 out of 38 publications